Innoviva, Inc. (INVA)
21.25
-0.10
(-0.47%)
USD |
NASDAQ |
Sep 04, 12:38
Innoviva Cash from Investing (Quarterly) : -55.26M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.26M |
| March 31, 2026 | 37.01M |
| December 31, 2025 | 23.64M |
| September 30, 2025 | 18.41M |
| June 30, 2025 | 33.12M |
| March 31, 2025 | -34.67M |
| December 31, 2024 | -15.48M |
| September 30, 2024 | -5.27M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -43.04M |
| December 31, 2023 | -5.151M |
| September 30, 2023 | -25.89M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -35.72M |
| December 31, 2022 | -10.19M |
| September 30, 2022 | 55.33M |
| June 30, 2022 | -2.522M |
| March 31, 2022 | -143.16M |
| December 31, 2021 | -19.90M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 90.02M |
| March 31, 2021 | -26.39M |
| December 31, 2020 | -315.48M |
| September 30, 2020 | -8.50M |
| June 30, 2020 | -7.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.04M |
| December 31, 2019 | 51.99M |
| September 30, 2019 | -15.94M |
| June 30, 2019 | 20.11M |
| March 31, 2019 | -74.17M |
| December 31, 2018 | -45.59M |
| September 30, 2018 | 13.52M |
| June 30, 2018 | 9.078M |
| March 31, 2018 | 26.51M |
| December 31, 2017 | -25.88M |
| September 30, 2017 | -21.77M |
| June 30, 2017 | 2.023M |
| March 31, 2017 | 22.40M |
| December 31, 2016 | 23.32M |
| September 30, 2016 | -15.10M |
| June 30, 2016 | -24.50M |
| March 31, 2016 | 11.69M |
| December 31, 2015 | 99.29M |
| September 30, 2015 | -47.88M |
| June 30, 2015 | 34.04M |
| March 31, 2015 | 73.71M |
| December 31, 2014 | -8.411M |
| September 30, 2014 | -59.54M |
| June 30, 2014 | -11.23M |
| March 31, 2014 | 14.13M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 31.45M |
| Collegium Pharmaceutical, Inc. | -502.59M |
| CorMedix, Inc. | -0.561M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 51.97M |
| Cash from Financing (Quarterly) | -29.40M |
| Free Cash Flow | 189.44M |
| Free Cash Flow Per Share (Quarterly) | 0.702 |
| Free Cash Flow to Equity (Quarterly) | 108.61M |
| Free Cash Flow to Firm (Quarterly) | 55.77M |
| Free Cash Flow Yield | 10.86% |